Concourse Financial Group Securities’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1126 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 3095 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 3092 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 3137 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 3148 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 3101 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 3104 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 3102 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 3074 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 3017 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2803 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2873 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2831 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 3008 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 2999 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2924 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 2870 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 2812 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 2676 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 2586 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2641 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2590 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 2287 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 2677 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2662 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2529 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2069 |
|